# Envarsus XR in Lung Transplant

> **NCT04420195** · PHASE2 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 41 (actual)

## Conditions studied

- Lung Transplant

## Interventions

- **DRUG:** Extended-Release Tacrolimus
- **DRUG:** Immediate-Release Tacrolimus

## Key facts

- **NCT ID:** NCT04420195
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-23
- **Primary completion:** 2022-11-30
- **Final completion:** 2022-11-30
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2024-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04420195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04420195, "Envarsus XR in Lung Transplant". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04420195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*